CERS Live signals | Maximize Profits with Getagraph.com

SELL 101805 min ago

@ $2.25

Issued: 14 Feb 2024 @ 09:30

Return: -26.22%

Previous signal: Feb 13 - 14:04

Previous signal: Buy

Return: 5.14 %

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety...

Stats
Today's Volume	579 742
Average Volume	1.62M
Market Cap	300.93M
EPS	$0 ( 2024-03-05 )
Next earnings date	( $-0.0400 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.90
ATR14	$0.00500 (0.30%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-12	Green Kevin Dennis	Buy	21 666	Common Stock
2024-03-13	Green Kevin Dennis	Sell	21 058	Common Stock
2024-03-14	Green Kevin Dennis	Sell	21 497	Common Stock
2024-03-12	Green Kevin Dennis	Sell	21 666	Restricted Stock Unit
2024-03-12	Moore Carol	Buy	11 666	Common Stock

INSIDER POWER
53.74
Last 100 transactions
Buy: 4 007 373 \| Sell: 1 157 608

Volume Correlation

Long: -0.06 (neutral)

Short: -0.85 (strong negative)

Signal:(36.898) Neutral

Cerus Corp Correlation

10 Most Positive Correlations
RGCO	0.924
DCRC	0.918
ASPS	0.912
VIEW	0.904
TIGR	0.903
LGHL	0.903
SFIX	0.899
VIASP	0.898
OP	0.897
LKFN	0.895

10 Most Negative Correlations
ARIZ	-0.918
PEP	-0.916
LBPH	-0.915
TWCB	-0.911
GLLI	-0.91
XPDB	-0.909
AVAC	-0.909
HWEL	-0.904
MDLZ	-0.903
PUCK	-0.901

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cerus Corp Correlation - Currency/Commodity

-0.19
( neutral )

-0.25
( neutral )

0.00
( neutral )

-0.05
( neutral )

Cerus Corp Financials

Annual	2023
Revenue:	$156.37M
Gross Profit:	$84.00M (53.72 %)
EPS:	$-0.210

Q4	2023
Revenue:	$46.77M
Gross Profit:	$25.31M (54.12 %)
EPS:	$-0.00730

Q3	2023
Revenue:	$39.77M
Gross Profit:	$21.82M (54.85 %)
EPS:	$-0.0402

Q2	2023
Revenue:	$38.85M
Gross Profit:	$21.34M (54.92 %)
EPS:	$-0.0735

Financial Reports:

No articles found.

Cerus Corp

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.